President & CEO – Prevencio, Inc.
Rhonda Rhyne has more than 25 years of C-suite level medical technology experience and is currently CEO and Board Director for Prevencio, Inc., a Kirkland-based company developing highly accurate, artificial intelligence (AI)-driven, multi-protein blood tests for heart disease and 1 year risk of heart attack, stroke and cardiac death. She also serves as Board Director for Aminex Therapeutics and OtoNexus Medical Technologies, both Seattle-area for-profit companies, as well as a Board Director for Life Science Washington (LSW), Washington State’s life science industry trade organization.
As a medical technology industry leader, Rhonda has received multiple awards, including Ernst & Young’s Entrepreneur of the Year–Medical Products, San Diego; Deloitte’s Fast 50 for 50 Fastest Growing Technology and Life Science Companies in Southern California for 9 consecutive years; San Diego’s Business Journal’s Women Who Mean Business; and Athena’s Pinnacle Individual in BioSciences.
Rhonda also authored the women’s leadership book, Keys to the Corner Office: Success Strategies for Women by Women. A portion of net proceeds is donated to OUR Rescue, a nonprofit dedicated to fighting sex trafficking.
Rhonda received her Bachelor of Pharmacy from Washington State University and MBA from University of California, Los Angeles (UCLA).
@rhondarhyne, www.linkedin.com/in/rhondarhyne, www.prevenciomed.com